40 related articles for article (PubMed ID: 6773844)
1. Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study.
Li W; Zhao X; Wang H; Liu X; Zhao X; Huang M; Qiu L; Zhang W; Chen Z; Guo W; Li J; Zhu X
Oncotarget; 2017 Jun; 8(23):37826-37834. PubMed ID: 27980221
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Tsujimoto S; Fujimoto K; Okajima E; Ozono S; Okajima E; Hirao Y
Int J Clin Oncol; 2008 Apr; 13(2):138-43. PubMed ID: 18463958
[TBL] [Abstract][Full Text] [Related]
3. EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.
Van den Brande J; Schöffski P; Schellens JH; Roth AD; Duffaud F; Weigang-Köhler K; Reinke F; Wanders J; de Boer RF; Vermorken JB; Fumoleau P
Br J Cancer; 2003 Mar; 88(5):648-53. PubMed ID: 12659110
[TBL] [Abstract][Full Text] [Related]
4. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo.
Shirasaka T; Shimamoto Y; Ohshimo H; Saito H; Fukushima M
Cancer Chemother Pharmacol; 1993; 32(3):167-72. PubMed ID: 8500219
[TBL] [Abstract][Full Text] [Related]
5. A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.
Inada T; Ogata Y; Kubota T; Ozawa I; Hishinuma S; Shimizu H; Kotake K; Ikeda T; Koyama Y
Surg Today; 1993; 23(8):687-92. PubMed ID: 8400672
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.
Maehara Y; Takeuchi H; Oshiro T; Takahashi I; Inutsuka S; Baba H; Kohnoe S; Sugimachi K
Cancer Chemother Pharmacol; 1994; 33(6):445-9. PubMed ID: 8137453
[TBL] [Abstract][Full Text] [Related]
7. Studies on the designing of chemotherapy for gastric cancer in man, based on the tumor tissue concentration of anticancer agents.
Suga S; Kimura K; Yokoyama Y; Isobe K; Yoshida Y; Takada T; Sato A; Kuwabara T; Iwase H
Gastroenterol Jpn; 1982; 17(4):295-300. PubMed ID: 6216137
[TBL] [Abstract][Full Text] [Related]
8. Report on nationwide pooled data and cohort investigation in UFT phase II study.
Ota K; Taguchi T; Kimura K
Cancer Chemother Pharmacol; 1988; 22(4):333-8. PubMed ID: 3139315
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.
Nishiyama M; Niimi K; Takagami S; Hirabayashi N; Yamaguchi M; Saeki T; Yoshinaka K; Wang DC; Niimoto M; Hattori T
Jpn J Surg; 1988 Jan; 18(1):93-7. PubMed ID: 3133515
[TBL] [Abstract][Full Text] [Related]
10. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
11. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
12. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
Kimura K; Suga S; Shimaji T; Kitamura M; Kubo K; Suzuoki Y; Isobe K
Gastroenterol Jpn; 1980; 15(4):324-9. PubMed ID: 6773844
[TBL] [Abstract][Full Text] [Related]
13. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
[TBL] [Abstract][Full Text] [Related]
14. Uracil-tegafur in gastric carcinoma: a comprehensive review.
Takiuchi H; Ajani JA
J Clin Oncol; 1998 Aug; 16(8):2877-85. PubMed ID: 9704742
[TBL] [Abstract][Full Text] [Related]
15. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
